Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

Dustin A. Carlson; Monique Hinchcliff; John E. Pandolfino

doi:10.1007/s11926-014-0475-y

Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

Dustin A. Carlson^*, Monique Hinchcliff, John E. Pandolfino

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

38 Scopus citations

Abstract

Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and esophageal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastroesophageal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions. In addition to reviewing GERD management in patients with SSc, present and potential uses of endoscopy, reflux monitoring, manometry, impedance planimetry, and endoscopic ultrasound are discussed.

Original language	English (US)
Journal	Current rheumatology reports
Volume	17
Issue number	1
DOIs	https://doi.org/10.1007/s11926-014-0475-y
State	Published - Jan 2015

Funding

This work was supported by RO1 DK079902 (J.E.P.) and T32 DK101363-01 (J.E.P) from the Public Health Service. It was also supported in part by an NIH-NIAMS K23 AR059763 (M.H.) and a research award from the Scleroderma Research Foundation (MH).

Keywords

Esophageal reflux monitoring
GERD
Impedance
Manometry
Systemic sclerosis

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s11926-014-0475-y

Cite this

@article{c7eaa73ec7154e70b07b13dc1cebd4b5,

title = "Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis",

abstract = "Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and esophageal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastroesophageal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions. In addition to reviewing GERD management in patients with SSc, present and potential uses of endoscopy, reflux monitoring, manometry, impedance planimetry, and endoscopic ultrasound are discussed.",

keywords = "Esophageal reflux monitoring, GERD, Impedance, Manometry, Systemic sclerosis",

author = "Carlson, {Dustin A.} and Monique Hinchcliff and Pandolfino, {John E.}",

note = "Publisher Copyright: {\textcopyright} 2014, Springer Science+Business Media New York.",

year = "2015",

month = jan,

doi = "10.1007/s11926-014-0475-y",

language = "English (US)",

volume = "17",

journal = "Current rheumatology reports",

issn = "1523-3774",

publisher = "Current Science, Inc.",

number = "1",

}

TY - JOUR

T1 - Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

AU - Carlson, Dustin A.

AU - Hinchcliff, Monique

AU - Pandolfino, John E.

PY - 2015/1

Y1 - 2015/1

N2 - Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and esophageal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastroesophageal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions. In addition to reviewing GERD management in patients with SSc, present and potential uses of endoscopy, reflux monitoring, manometry, impedance planimetry, and endoscopic ultrasound are discussed.

AB - Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and esophageal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastroesophageal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions. In addition to reviewing GERD management in patients with SSc, present and potential uses of endoscopy, reflux monitoring, manometry, impedance planimetry, and endoscopic ultrasound are discussed.

KW - Esophageal reflux monitoring

KW - GERD

KW - Impedance

KW - Manometry

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84940900836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940900836&partnerID=8YFLogxK

U2 - 10.1007/s11926-014-0475-y

DO - 10.1007/s11926-014-0475-y

M3 - Review article

C2 - 25475597

AN - SCOPUS:84940900836

SN - 1523-3774

VL - 17

JO - Current rheumatology reports

JF - Current rheumatology reports

IS - 1

ER -

Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this